Product Information
FLECAINIDE ACETATE 50 MG TAB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1118 per EA under NDC 00054001025. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jan 14, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the flecainide acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054001025
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FLECAINIDE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA076278FDA Approved
1/14/2003
TE Code
AB
On Market Since
1/14/2003
Pharmacological Classes
Price Statistics
The NADAC for FLECAINIDE ACETATE 50 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 36.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1118 per EA |
|---|---|
| All-time high | $0.4893 (Apr 15, 2015) |
| All-time low | $0.0874 (Nov 20, 2024) |
| 52-week high | $0.1162 |
| 52-week low | $0.1099 |
| Median price | $0.2053 |
| Average price | $0.1944 |
| Largest weekly change | +115.0% (Mar 18, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FLECAINIDE ACETATE 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FLECAINIDE ACETATE 50 MG TAB, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1118 per EA (NDC 00054001025), effective Aug 19, 2026.
How has the price of FLECAINIDE ACETATE 50 MG TAB changed over time?
Over the history we have for it, the NADAC for FLECAINIDE ACETATE 50 MG TAB has declined 36.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLECAINIDE ACETATE 50 MG TAB?
Since Nov 28, 2013, the NADAC for FLECAINIDE ACETATE 50 MG TAB has ranged from a low of $0.0874 (Nov 20, 2024) to a high of $0.4893 (Apr 15, 2015), with a median of $0.2053 per EA.
Are there cheaper alternatives to FLECAINIDE ACETATE 50 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLECAINIDE ACETATE 50 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures FLECAINIDE ACETATE 50 MG TAB?
FLECAINIDE ACETATE 50 MG TAB (NDC 00054001025) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.